Awakn Life Sciences is developing medication-assisted treatments (MATs) that target brain circuits associated with addiction, specifically focusing on Alcohol Use Disorder (AUD), which affects millions globally. Their evidence-based approach aims to improve treatment outcomes and reduce relapse rates by enabling patients to engage in psychotherapeutic processes that foster lasting behavioral change.
Funding
$535K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Alcohol Use Disorder (AUD) affects millions globally, with current standard treatments often proving inadequate, leading to high relapse rates and significant direct medical costs. Existing treatments often fail to address the underlying brain circuits that drive addiction, limiting their long-term effectiveness.
Solution
Awakn Life Sciences is developing medication-assisted treatments (MATs) that target the brain circuits associated with addiction, specifically focusing on AUD. Their evidence-based approach combines pharmaceutical interventions with psychotherapeutic processes to enable lasting behavioral change. By disrupting the behavioral drivers of addiction, Awakn's MATs allow individuals to escape repetitive addictive behaviors and thoughts, facilitating engagement with psychotherapy. The therapies are manualized and protocols are condensed to ensure efficient use of healthcare resources.
Target Audience
The primary target audience includes individuals suffering from Alcohol Use Disorder, healthcare providers specializing in addiction treatment, and pharmaceutical companies seeking to expand their offerings in the addiction therapeutics market.
Features
- AWKN-001: Medication-assisted treatment for Alcohol Use Disorder (AUD).
- AWKN-002: Investigational treatment for addiction.
- Targets brain circuits that control the behavioral drivers of addiction.
- Manualized therapies and condensed protocols for efficient healthcare resource utilization.
- Potential to expand into other addiction treatments.